Frederick F. Lang

OverviewAI-generated summary

Frederick F. Lang is a faculty member at the University of Arkansas for Medical Sciences. His research program focuses on oncological patient care, specifically investigating treatment strategies for brain tumors and hematological conditions in cancer patients. Lang has published work on the management of chronic subdural hematoma in oncological patients, comparing surgical drainage with middle meningeal artery embolization. His publications also address the role of oncogenic drivers in shaping the tumor microenvironment of human gliomas and the impact of brain metastases on patient survival in non-small cell lung cancer treated with immune checkpoint inhibitors.

Lang is currently PI on a $76,500 NIH/National Cancer Institute grant to develop immunocompetent melanoma brain metastases organoids. His work also includes a phase 1/2 trial on oncolytic DNX-2401 virotherapy combined with pembrolizumab for recurrent glioblastoma. Further research interests include the molecular and clinical determinants of response to immunotherapy in high-grade glioma and the surgical management of infiltrative gliomas. Lang's scholarship metrics include an h-index of 6, with 14 total publications and over 1,055 citations.

Metrics

• h-index: 6
• Publications: 14
• Citations: 1,055